P2Y1 purinergic receptor identified as a diabetes target in a small-molecule screen to reverse circadian beta-cell failure.

Marcheva B, Weidemann BJ, Taguchi A, Perelis M, Ramsey KM, Newman MV, Kobayashi Y, Omura C, Manning Fox JE, Lin H, Macdonald PE, Bass J
Elife. 2022 Feb 21;11. pii: 75132. doi: 10.7554/eLife.75132. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.